Ross Errington
Head of Drug Product Development

About

Ross Errington, Head of Drug Product Development, is a chemist by training. He has over 30 years’ experience in pharmaceutical product development and manufacture, specialising in inhaled delivery systems. He has deep experience of pMDI product development and commercialisation, having supported numerous customers to successfully design, develop, register and commercialise products across global markets.

Mr Errington is also an International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) board member.

Contributions

SUSTAINABILITY

REFORMULATING pMDIS WITH NEXT-GENERATION SUSTAINABLE PROPELLANTS

Ross Errington and Simon Gardner, discuss sustainability and the reformulation of pMDIs with low-GWP propellants.

More contributions

EXPERT VIEW

FUTURE-PROOFING pMDI DESIGN TO FIT A CHANGING MARKET

Ross Errington explores how pharmaceutical companies can evolve their pMDI drug products to make them fit for the future considering the several recent regulatory changes that are transforming the landscape of inhalation drugs.

NASAL

NAVIGATING THE CHALLENGES OF BRINGING INTRANASAL DRUG FORMULATIONS & DEVICES TO PATIENTS

Joe Neale and Ross Errington explore the obstacles and opportunities facing the intranasal drug delivery market and how manufacturers can overcome them by harnessing innovative platforms like Unidose^® Xtra.